The moves were approved at a Teva shareholders meeting today. Sources inform "Globes" that several dozen shareholders were present at the meeting, and that many of them expressed strong opposition to the motions on the agenda. However, Teva had the majority required to pass them, mainly thanks to...
FULL ARTICLE AT Globes Online